Reference SummarySmith GH, Am J Pathol 1995 Oct;147(4):1081-96
Title |
Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. | ||||
Authors |
Smith GH; Sharp R; Kordon EC; Jhappan C; Merlino G | ||||
Journal |
Am J Pathol | ||||
Volume |
147 | ||||
Issue |
4 | ||||
Year |
1995 | ||||
Pages |
1081-96 | ||||
Abstract |
Transforming growth factor (TGF)-alpha stimulates the growth and development of mammary epithelial cells and is implicated in the pathogenesis of human breast cancer. In this report we evaluate the consequences of overexpressing TGF-alpha in the mammary gland of transgenic mice and examine associated cellular mechanisms. When operating on a FVB/N genetic background (line MT100), TGF-alpha induced the stochastic development of mammary adenomas and adenocarcinomas f secretory epithelial origin in 64% of multiparous females. In contrast, tumors were exceedingly rare in virgin MT100 females, MT100 males, and multiparous FVB/N females. In MT100 females multiple foci of hyperplastic secretory lesions preceded the development of frank tumors; these initial lesions appeared during the involution period after the first lactation. Serial transplantation of these hyperplasias indicated an absence of proliferative immortality. Nevertheless, they gave rise to tumors at a low frequency and after a prolonged latency in virgin hosts; in multiparous hosts, tumors developed earlier and at a high incidence. The TGF-alpha transgene was highly expressed in hyperplasias and tumors but not in virgin and nonlesion-bearing tissue, suggesting that TGF-alpha overexpression provides a selective growth advantage. TGF-alpha also induced at lactation a 6.4-fold increase in DNA synthesis in MT100 epithelial cells, many of which were binucleated. MT100 mammary tissue experienced an obvious delay in involution, resulting in the postlactational survival of a significant population of unregressed secretory epithelial cells. In contrast, another line of transgenic mice on a CD-1 genetic background (MT42), in which TGF-alpha overexpression induced liver but not mammary tumors, failed to demonstrate postlactational epithelial cell survival. These data show that TGF-alpha promotes mammary tumorigenesis in multiparous MT100 mice by stimulating secretory epithelial cell proliferation during lactation and prolonging survival during involution. These points support the notion that TGF-alpha can act as a mitogen and also as a differentiation factor in mammary epithelium. | ||||
Links |
J:72083 – MGI References 7573353 – National Library of Medicine/PubMed |
||||
Strain Notes
|
|||||
| Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
|---|---|---|---|---|---|
| FVB/N-Tg(MtTGFA)100Lmb | Mammary gland adenocarcinoma |
|
Mammary gland |
observed - 48 |
|
| FVB/N-Tg(MtTGFA)100Lmb | Mammary gland adenoma |
|
Mammary gland |
0 - 15 |
|
| FVB/N-Tg(MtTGFA)100Lmb | Mammary gland hyperplasia |
|
Mammary gland |
observed |
|
| FVB/N | Mammary gland tumor | Mammary gland |
0 |
||
| CD-1-Tg(MtTGFA)42Lmb | Mammary gland tumor | Mammary gland |
observed |